Filing Flows

Filing Flows › Health Care › Essence Array

Essence Array earnings and revenue breakdown

Latest: Q2 FY27 · 10-Q filed Oct 20, 2026

Q2 FY27 57¢ of every $1 of revenue lost · operating margin -57.3%

Essence Array made $5K in Q2 FY27. Operating margin -57.3%, net loss $3K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 20, 2026.

Revenue$5K
Year over year—
Operating margin-57.3%
Net earnings−$3K
Operating cash flow−$3K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $5K in Q2 FY27, down 72% from the previous quarter.

Operating costs exceeded revenue by $3K, an operating margin of -57.3%. The quarter ended with a net loss of $3K, after a profit of $1K the previous quarter.

Operating cash flow was −$3K. Working capital and other items used $0K.

Quarterly history

Essence Array revenue by quarterEssence Array revenue by quarter$13KQ3 FY26$5KQ4 FY26$17KQ1 FY27$5KQ2 FY27
Essence Array net earnings by quarterEssence Array net earnings by quarter$8KQ3 FY26−$2KQ4 FY26$1KQ1 FY27−$3KQ2 FY27
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 FY2710-QOct 20, 2026$5K—-57.3%−$3K−$3K
Q1 FY2710-QJul 28, 2026$17K—7.3%$1K$2K
Q4 FY2610-KApr 24, 2026$5K—-36.8%−$2K−$2K
Q3 FY2610-QJan 27, 2026$13K—60.2%$8K−$1K

Charts

Essence Array: revenue growth, year over year and quarter over quarterEssence Array: revenue growth, year over year and quarter over quarterY/YQ/Q-61%Q4 FY26+230%Q1 FY27-72%Q2 FY27
Latest (Q2 FY27): Y/Y —, Q/Q -72%.
Essence Array: where the cash came from (+) and went (−), TTM to Q2 FY27Essence Array: where the cash came from (+) and went (−), TTM to Q2 FY27Shares issued$37KCash drawn (+) / kept (−)−$28KNot reconciled−$5KOperating cash flow−$4K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Essence Array: profit against cash, quarter by quarterEssence Array: profit against cash, quarter by quarterNet incomeOperating cash flow$0Q2 FY25−$163−$473Q3 FY25−$7K−$7KQ1 FY26−$2K$7KQ2 FY26$8K−$1KQ3 FY26−$2K−$2KQ4 FY26$1K$2KQ1 FY27−$3K−$3KQ2 FY27
Latest (Q2 FY27): Net income −$3K, Operating cash flow −$3K.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Essence Array

ESSENCE ARRAY INC. (the “Company”) was incorporated under the laws of the State of Wyoming on March 29, 2024. The Company’s fiscal year ends on March 31. The Company is a startup engaged in the sourcing and distribution of natural health and beauty products.

In its own words, from its 10-Q, filed Jul 28, 2026.

Essence Array against its Wholesale-Drugs, Proprietaries & Druggists' Sundries peers

The largest companies of the same SEC industry, each at its latest quarter. Operating margin: -57.3% against the peers' median 1.1%.

CompanyQuarterRevenueY/YOp. margin
Essence ArrayQ2 FY27$5K—-57.3%
MCK McKessonQ2 FY27$111.0B+8%1.4%
COR CencoraQ3 FY26$84.8B+5%1.3%
CAH Cardinal HealthQ1 FY27$67.5B+6%1.1%
HLF HerbalifeQ3 2026$1.4B+6%10.3%
NUS Nu Skin EnterprisesQ3 2026$311M-15%1.6%
COSM Cosmos HealthQ2 2026$19.0M+29%-15.4%
MEDS DataMeds AIQ2 2026$1.8M-77%-412.7%
STEK StemtechQ2 2026$629K-10%-20.0%

Source: Essence Array 10-Q on SEC EDGAR · CIK 2064765 · Wholesale-Drugs, Proprietaries & Druggists' Sundries